Long-term cardiovascular toxicity in children, adolescents, and young adults who receive cancer therapy: Pathophysiology, course, monitoring, management, prevention, and research directions: A scientific statement from the American Heart Association

Steven E. Lipshultz, M. Jacob Adams, Steven D. Colan, Louis S. Constine, Eugene H. Herman, Daphne T. Hsu, Melissa M. Hudson, Leontien C. Kremer, David C. Landy, Tracie L. Miller, Kevin C. Oeffinger, David N. Rosenthal, Craig A. Sable, Stephen E. Sallan, Gautam K. Singh, Julia Steinberger, Thomas R. Cochran, James D. Wilkinson

Research output: Contribution to journalArticle

244 Scopus citations
Original languageEnglish
Pages (from-to)1927-1955
Number of pages29
JournalCirculation
Volume128
Issue number17
DOIs
StatePublished - Oct 22 2013
Externally publishedYes

Keywords

  • AHA Scientific Statements
  • adolescent
  • antineoplastic agents
  • cancer
  • children
  • prevention and control
  • toxicity

Cite this

Lipshultz, S. E., Adams, M. J., Colan, S. D., Constine, L. S., Herman, E. H., Hsu, D. T., Hudson, M. M., Kremer, L. C., Landy, D. C., Miller, T. L., Oeffinger, K. C., Rosenthal, D. N., Sable, C. A., Sallan, S. E., Singh, G. K., Steinberger, J., Cochran, T. R., & Wilkinson, J. D. (2013). Long-term cardiovascular toxicity in children, adolescents, and young adults who receive cancer therapy: Pathophysiology, course, monitoring, management, prevention, and research directions: A scientific statement from the American Heart Association. Circulation, 128(17), 1927-1955. https://doi.org/10.1161/CIR.0b013e3182a88099